Scott Bizily's Stock Transactions in 4D Molecular Therapeutics, Inc.

Scott Bizily, an officer at 4D Molecular Therapeutics, Inc., has filed a Form 144 notice detailing his stock transactions. The filing includes the exercise of stock options for 222 common shares and the acquisition of 1594 common shares through the Employee Stock Purchase Plan. Additionally, Bizily has sold 1816 common shares in the past three months, with the most recent sale on October 16, 2025, totaling $16,627.95. The transactions were executed under a 10b5-1 trading plan, indicating pre-planned sales. The filing provides transparency into Bizily's stock activities and compliance with SEC regulations.